The effects of preparations of traditional medicine in infertility

The effect of traditional medicine products on the success of Intrauterine Insemination (IUI) in infertile women

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016111130827N1

Enrollment

432

Registered

2017-10-29

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Infertility due to anovulation. Condition 2: Infertility due to male factors. Condition 3: Infertility of women with unknown cause. Female infertility associated with anovulation Female infertility associated with male factors Female infertility, unspecified

Interventions

Intervention 1: Control groups: Routine care. Intervention 2: Intervention group: From 7th day of menstruation until the day that will be done intrauterine insemination,Combination products (1%)con

Treatment - Other

Treatment - Drugs

Control groups: Routine care

Intervention group: From 7th day of menstruation until the day that will be done intrauterine insemination,Combination products (1%)containing honey and myristica fragrans will be used into vagina

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Infertile women candidates for Intrauterine Insemination (IUI) (Infertility due to anovulation, male factor infertility and unexplained infertility) ; All patients are first IUI; Age between 20 and 40 years; Infertility below 15 years; Sperm count over 5 million sperm per milliliter after preparation; Normal hormone tests; The uterus is normal in Hysterosalpingography (HSG) and at least has one open Fallopian tube exclusion criteria: Body Mass Index (BMI) more than 35; Follicle diameter unsuitable for injection of Human Chorionic Gonadotropin (HCG); Endometriosis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: 16 days after intrauterine insemination. Method of measurement: Measurement of serum ßHCG.;Clinical pregnancy. Timepoint: 6 weeks after intrauterine insemination. Method of measurement: vaginal sonography.	—

Secondary

Measure	Time frame
Drugs side effect. Timepoint: daily. Method of measurement: Patient reports.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Kavousi

Mashhad University of Medical Sciences

kavousim921@mums.ac.ir+98 51 3855 2189

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026